rpsL Resolved · high auto-curated

H37Rv Rv0682 · MTBC0 mtbc0_000721 · 124 aa · 785646–786020 MTBC0 (+) · RefSeq NP_215196.1

Genomic neighbourhood (genome browser)

Open in full genome browser →
+ strand − strand end (Rv0670) — requalified: deoxyribonuclease IV lpqP (Rv0671) — family_assigned: PHB depolymerase family esterase lpqP fadE8 (Rv0672) — family_assigned: acyl-CoA dehydrogenase family protein fadE8 echA4 (Rv0673) — family_assigned: crotonase/enoyl-CoA hydratase family protein echA4 Rv0674 (Rv0674) — family_assigned: PaaX family transcriptional regulator C-terminal domain-cont mmpL5 (Rv0676c) — requalified: siderophore RND transporter MmpL5 mmpL5 mmpS5 (Rv0677c) — requalified: siderophore transporter accessory protein MmpS5 mmpR5 (Rv0678) — family_assigned: siderophore transport transcriptional regulator MmpR5 Rv0679c (Rv0679c) — family_assigned: DUF3060 domain-containing protein Rv0680c (Rv0680c) — dark: DUF3060 domain-containing protein Rv0681 (Rv0681) — family_assigned: TetR/AcrR family transcriptional regulator rpsL (Rv0682) — requalified: 30S ribosomal protein S12 Rv0686 (Rv0686) — family_assigned: SHOCT domain-containing protein Rv0687 (Rv0687) — family_assigned: Rv0687 family mycofactocin-dependent SDR oxidoreductase Rv0687 Rv0688 (Rv0688) — requalified: FAD/NAD(P)-binding oxidoreductase Rv0688 Rv0690c (Rv0690c) — family_assigned: DUF2332 domain-containing protein Rv0690c mftR (Rv0691c) — family_assigned: mycofactocin system transcriptional regulator mftB (Rv0692) — requalified: mycofactocin biosynthesis chaperone MftB mftC (Rv0693) — requalified: mycofactocin radical SAM maturase mftC mftD (Rv0694) — requalified: pre-mycofactocin synthase MftD 776 kb 780 kb 784 kb 788 kb 792 kb 796 kb

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)30S ribosomal protein S12
MTBC0 PGAP re-annotation30S ribosomal protein S12
Revised (this work)30S ribosomal protein S12. Pfam: Ribosom_S12_S23 (PF00164.32).
Functional category (TubercuList)information pathways

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 244 publications

244 TB publications mention this gene. 244 publications discuss this gene. Queried separately, 229 records carry a M. tuberculosis context and 16 a non-TB mycobacterial context (species named in the 16-record verified sample: M. smegmatis (13), M. abscessus (2), M. leprae (2), M. marinum (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 244: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Analysis of Drug Resistance Characteristics and Risk Factors of Cavitary Tuberculosis Based on Whole Genome Sequencing and Machine Learning. doi:10.1093/ofid/ofag328 2026
Effects of nanozyme on environmental fate and dissemination of antibiotic resistance genes in anaerobically digested sludge. doi:10.1016/j.biortech.2026.134325 2026
Investigation of Gene Regions Responsible for Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis Complex Resistant to at Least Two First-Line Anti-Tuberculosis Drugs. doi:10.3390/pathogens15020222 2026
In Silico Design of gRNA for CRISPR System for Detection of Multidrug Resistant Tuberculosis Using Indian Mycobacterium tuberculosis Genomes: A Computational Study. doi:10.7759/cureus.101851 2026
First insight of characteristics and prediction of Mycobacterium tuberculosis drug resistance by whole genome sequencing in Fujian Province, China. doi:10.1038/s41598-026-40398-6 2026
244 records returned by the alias sweep

Searched as: Rv0682, rpsL, Mb0701, ML1880c, MMAR_1011, MSMEG_1398, MAB_3851c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Analysis of Drug Resistance Characteristics and Risk Factors of Cavitary Tuberculosis Based on Whole Genome Sequencing and Machine Learning. doi:10.1093/ofid/ofag328 Open Forum Infect Dis 2026
Effects of nanozyme on environmental fate and dissemination of antibiotic resistance genes in anaerobically digested sludge. doi:10.1016/j.biortech.2026.134325 Bioresour Technol 2026
Investigation of Gene Regions Responsible for Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis Complex Resistant to at Least Two First-Line Anti-Tuberculosis Drugs. doi:10.3390/pathogens15020222 Pathogens 2026
In Silico Design of gRNA for CRISPR System for Detection of Multidrug Resistant Tuberculosis Using Indian Mycobacterium tuberculosis Genomes: A Computational Study. doi:10.7759/cureus.101851 Cureus 2026
First insight of characteristics and prediction of Mycobacterium tuberculosis drug resistance by whole genome sequencing in Fujian Province, China. doi:10.1038/s41598-026-40398-6 Sci Rep 2026
Characterization of pulmonary tuberculosis in high-altitude region using nanopore targeted sequencing. doi:10.1186/s12866-026-04761-x BMC Microbiol 2026
The genetic diversity of drug resistance in Mycobacterium tuberculosis strains from the Tibetan Plateau. doi:10.1016/j.jiph.2025.103120 J Infect Public Health 2026
Case Report: NGS-guided rapid diagnosis of tuberculous otitis media-a rare case of dual-site Mycobacterium tuberculosis infection. doi:10.3389/fmed.2025.1734666 Front Med (Lausanne) 2025
Key resistance-associated mutations in multidrug-resistant tuberculosis: a genomic study from Shanghai, China, with a focus on aminoglycosides. doi:10.1186/s12866-025-04446-x BMC Microbiol 2025
Whole-genome sequencing for analyzing the transmission characteristics of drug-resistant Mycobacterium tuberculosis in Ganzhou, China. doi:10.1186/s12879-025-11356-w BMC Infect Dis 2025
Lineage identification and mutation profile of Mycobacterium tuberculosis: A study from National Reference Laboratory, India. doi:10.1016/j.ijmmb.2025.100925 Indian J Med Microbiol 2025
Nanopore-based targeted sequencing (NTS) for drug-resistant tuberculosis: an integrated tool for personalized treatment strategies and guidance for new drug development. doi:10.1186/s12879-025-11227-4 BMC Infect Dis 2025
Prevalence and molecular characterization of drug-resistant Mycobacterium tuberculosis in Heyuan City in China. doi:10.3389/fcimb.2025.1586938 Front Cell Infect Microbiol 2025
High incidence of TB at a psychiatric hospital. doi:10.5588/ijtldopen.24.0684 IJTLD Open 2025
An exploratory study on the application of nanopore sequencing for detecting Mycobacterium tuberculosis drug resistance in respiratory specimens. doi:10.1186/s12890-025-03747-1 BMC Pulm Med 2025
Whole-genome sequencing analysis to identify antimicrobial resistance regions and virulence factors in Mycobacterium tuberculosis isolates from the Amhara Region, Ethiopia. doi:10.1038/s41598-025-01241-6 Sci Rep 2025
Genetic diversity and transmission pattern of multidrug-resistant tuberculosis based on whole-genome sequencing in Wuhan, China. doi:10.3389/fpubh.2025.1442987 Front Public Health 2025
Genetic variations underlying aminoglycoside resistance in antibiotic-induced Mycobacterium intracellulare mutants. doi:10.1016/j.meegid.2025.105716 Infect Genet Evol 2025
Bifidobacterium adolescentis is resistant to pyrazinamide, isoniazid, and streptomycin. doi:10.1038/s41598-024-78095-x Sci Rep 2024
Genetic diversities and drug resistance in Mycobacterium bovis isolates from zoonotic tuberculosis using whole genome sequencing. doi:10.1186/s12864-024-10909-8 BMC Genomics 2024
Exploring gene mutations and multidrug resistance in Mycobacterium tuberculosis: a study from the Lung Hospital in Vietnam. doi:10.1007/s11033-024-10015-8 Mol Biol Rep 2024
Discovery of anti-Mycobacterium tuberculosis desertomycins from Streptomyces flavofungini TRM90047 based on genome mining and HSQC-TOCSY. doi:10.1038/s41598-024-65702-0 Sci Rep 2024
Construction of knockout mutants in Mycobacterium intracellulare ATCC13950 strain using a thermosensitive plasmid containing negative selection marker rpsL(). doi:10.1111/1348-0421.13167 names it Microbiol Immunol 2024
Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Multidrug-Resistant Mycobacterium tuberculosis in Jiangxi, China. doi:10.2147/IDR.S460267 Infect Drug Resist 2024
Targeted suppression of MEP pathway genes DXS, IspD and IspF to explore the mycobacterial metabolism and survival. doi:10.1016/j.ijbiomac.2024.132727 Int J Biol Macromol 2024
Discordance in Phenotypic and Genotypic Susceptibility Testing for Streptomycin Due to Nonsynonymous/Nonsense/Deletion Frame-Shift Mutations in gidB among Clinical Mycobacterium tuberculosis Isolates in Kuwait. doi:10.1159/000538584 Med Princ Pract 2024
Whole Genome Sequence-Based Analyses of Drug Resistance Characteristics, Genetic Diversity, and Transmission Dynamics of Drug-Resistant Mycobacterium tuberculosis in Urumqi City. doi:10.2147/IDR.S454913 Infect Drug Resist 2024
Concordance of targeted and whole genome sequencing for Mycobacterium tuberculosis genotypic drug susceptibility testing. doi:10.1016/j.diagmicrobio.2024.116249 Diagn Microbiol Infect Dis 2024
Rapid detection of multidrug resistance in tuberculosis using nanopore-based targeted next-generation sequencing: a multicenter, double-blind study. doi:10.3389/fmicb.2024.1349715 Front Microbiol 2024
Analysis of Antibiotic Resistance Genes in Water Reservoirs and Related Wastewater from Animal Farms in Central China. doi:10.3390/microorganisms12020396 Microorganisms 2024
Selection of Multi-Drug Targets against Drug-Resistant Mycobacterium tuberculosis XDR1219 Using the Hyperbolic Mapping of the Protein Interaction Network. doi:10.3390/ijms241814050 Int J Mol Sci 2023
Whole genome sequencing of drug resistance Mycobacterium tuberculosis from extra-pulmonary sites. doi:10.26508/lsa.202302076 Life Sci Alliance 2023
Whole Genomic Analysis Revealed High Genetic Diversity and Drug-Resistant Characteristics of Mycobacterium tuberculosis in Guangxi, China. doi:10.2147/IDR.S410828 Infect Drug Resist 2023
Deciphering the emerging role of phytocompounds: Implications in the management of drug-resistant tuberculosis and ATDs-induced hepatic damage. doi:10.1016/j.jiph.2023.07.016 J Infect Public Health 2023
Insight into Population Structure and Drug Resistance of Pediatric Tuberculosis Strains from China and Russia Gained through Whole-Genome Sequencing. doi:10.3390/ijms241210302 Int J Mol Sci 2023
Insight into pathogenomics and phylogeography of hypervirulent and highly-lethal Mycobacterium tuberculosis strain cluster. doi:10.1186/s12879-023-08413-7 BMC Infect Dis 2023
Whole-genome sequencing reveals genotypic resistance in phenotypically susceptible Mycobacterium tuberculosis clinical isolates. doi:10.4103/ijmy.ijmy_101_23 Int J Mycobacteriol 2023
Emergence and evolution of drug-resistant Mycobacterium tuberculosis in eastern China: A six-year prospective study. doi:10.1016/j.ygeno.2023.110640 Genomics 2023
A rapid, accurate, and low-cost method for detecting Mycobacterium tuberculosis and its drug-resistant genes in pulmonary tuberculosis: Applications of MassARRAY DNA mass spectrometry. doi:10.3389/fmicb.2023.1093745 Front Microbiol 2023
Whole-genome sequencing-based analyses of drug-resistant Mycobacterium tuberculosis from Taiwan. doi:10.1038/s41598-023-29652-3 Sci Rep 2023
Drug Resistance and Molecular Characteristics of Mycobacterium tuberculosis: A Single Center Experience. doi:10.3390/jpm12122088 J Pers Med 2022
Genomic analysis of Mycobacterium tuberculosis variant bovis strains isolated from bovine in the state of Mato Grosso, Brazil. doi:10.3389/fvets.2022.1006090 Front Vet Sci 2022
Evaluation of Mutations Related to Streptomycin Resistance in Mycobacterium tuberculosis Clinical Isolates. doi:10.1007/s00284-022-03043-9 Curr Microbiol 2022
Acquisition of Streptomycin Resistance by Oxidative Stress Induced by Hydrogen Peroxide in Radiation-Resistant Bacterium Deinococcus geothermalis. doi:10.3390/ijms23179764 Int J Mol Sci 2022
Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia. doi:10.1371/journal.pone.0271508 PLoS One 2022
Drug resistant Mycobacterium tuberculosis in Oman: resistance-conferring mutations and lineage diversity. doi:10.7717/peerj.13645 PeerJ 2022
Whole-Genome Sequencing for Resistance Level Prediction in Multidrug-Resistant Tuberculosis. doi:10.1128/spectrum.02714-21 Microbiol Spectr 2022
[Exploratory study on detection of drug resistance of Mycobacterium tuberculosis in sputum specimens by next-generation sequencing]. doi:10.3760/cma.j.cn112147-20211104-00775 Zhonghua Jie He He Hu Xi Za Zhi 2022
Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients. doi:10.1016/j.tube.2022.102209 Tuberculosis (Edinb) 2022
Intra-host genetic population diversity: Role in emergence and persistence of drug resistance among Mycobacterium tuberculosis complex minor variants. doi:10.1016/j.meegid.2022.105288 Infect Genet Evol 2022
Characterization of Fluoroquinolone-Resistant and Multidrug-Resistant Mycobacterium tuberculosis Isolates Using Whole-Genome Sequencing in Tianjin, China. doi:10.2147/IDR.S361635 Infect Drug Resist 2022
Application of Amplicon-Based Targeted NGS Technology for Diagnosis of Drug-Resistant Tuberculosis Using FFPE Specimens. doi:10.1128/spectrum.01358-21 Microbiol Spectr 2022
Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China. doi:10.1128/spectrum.01475-21 Microbiol Spectr 2022
Abattoir survey of bovine tuberculosis in tanta, centre of the Nile delta, with in silico analysis of gene mutations and protein-protein interactions of the involved mycobacteria. doi:10.1111/tbed.14001 Transbound Emerg Dis 2022
Whole Genome Sequencing of Drug Resistant and Drug Susceptible Mycobacterium tuberculosis Isolates From Tigray Region, Ethiopia. doi:10.3389/fmicb.2021.743198 Front Microbiol 2021
Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China. doi:10.3390/antibiotics10111367 Antibiotics (Basel) 2021
The whole-genome sequencing in predicting Mycobacterium tuberculosis drug susceptibility and resistance in Papua, Indonesia. doi:10.1186/s12864-021-08139-3 BMC Genomics 2021
Characterization of Mutations Associated with Streptomycin Resistance in Multidrug-Resistant Mycobacterium tuberculosis in Zambia. doi:10.3390/antibiotics10101169 Antibiotics (Basel) 2021
Whole-genome sequencing as a tool for studying the microevolution of drug-resistant serial Mycobacterium tuberculosis isolates. doi:10.1016/j.tube.2021.102137 Tuberculosis (Edinb) 2021
Prevalence and Molecular Characteristics Based on Whole Genome Sequencing of Mycobacterium tuberculosis Resistant to Four Anti-Tuberculosis Drugs from Southern Xinjiang, China. doi:10.2147/IDR.S320024 Infect Drug Resist 2021
Emerging MDR-Mycobacterium avium subsp. avium in house-reared domestic birds as the first report in Egypt. doi:10.1186/s12866-021-02287-y BMC Microbiol 2021
A novel mechanism of streptomycin resistance in Yersinia pestis: Mutation in the rpsL gene. doi:10.1371/journal.pntd.0009324 names it PLoS Negl Trop Dis 2021
Molecular Characteristics and Drug Resistance of Mycobacterium tuberculosis Isolate Circulating in Shaanxi Province, Northwestern China. doi:10.1089/mdr.2020.0496 Microb Drug Resist 2021
Exploratory development of PCR-fluorescent probes in rapid detection of mutations associated with extensively drug-resistant tuberculosis. doi:10.1007/s10096-021-04236-z Eur J Clin Microbiol Infect Dis 2021
Molecular epidemiology of Mycobacterium tuberculosis in adult Filipino TB-HIV co-infected patients. doi:10.5588/ijtld.20.0878 Int J Tuberc Lung Dis 2021
Drug-Resistant Mycobacterium tuberculosis Isolates from New and Previously Treated TB Patients in China, 2017-2019. doi:10.1590/0037-8682-0728-2020 Rev Soc Bras Med Trop 2021
Genome analyses of 174 strains of Mycobacterium tuberculosis provide insight into the evolution of drug resistance and reveal potential drug targets. doi:10.1099/mgen.0.000542 Microb Genom 2021
Simultaneous Detection of Drug-resistant Mutations in Mycobacterium tuberculosis and Determining their Role through In Silico Docking. doi:10.2174/1871526520666200318111140 Infect Disord Drug Targets 2021
Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB. doi:10.1371/journal.pone.0244829 PLoS One 2020
Molecular analysis of streptomycin-resistance associating genes in Mycobacterium tuberculosis isolates from Nepal. doi:10.1016/j.tube.2020.101985 Tuberculosis (Edinb) 2020
Genomic Analysis Identifies Mutations Concerning Drug-Resistance and Beijing Genotype in Multidrug-Resistant Mycobacterium tuberculosis Isolated From China. doi:10.3389/fmicb.2020.01444 Front Microbiol 2020
Survey of drug resistance associated gene mutations in Mycobacterium tuberculosis, ESKAPE and other bacterial species. doi:10.1038/s41598-020-65766-8 Sci Rep 2020
Genomic signatures of drug resistance in highly resistant Mycobacterium tuberculosis strains of the early ancient sublineage of Beijing genotype in Russia. doi:10.1016/j.ijantimicag.2020.106036 Int J Antimicrob Agents 2020
[Analysis on drug resistance-associated mutations of multi-drug resistant Mycobacterium tuberculosis based on whole-genome sequencing in China]. doi:10.3760/cma.j.cn112338-20191111-00800 Zhonghua Liu Xing Bing Xue Za Zhi 2020
Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears. doi:10.1371/journal.pone.0232343 PLoS One 2020
Metabolic Changes of Mycobacterium tuberculosis during the Anti-Tuberculosis Therapy. doi:10.3390/pathogens9020131 Pathogens 2020
Phenotypic and Genotypic Characterization of Streptomycin-Resistant Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Southern China. doi:10.1089/mdr.2019.0245 Microb Drug Resist 2020
Bacillus Calmette-Guérin strains with defined resistance mutations: a new tool for tuberculosis laboratory quality control. doi:10.1016/j.cmi.2019.10.033 Clin Microbiol Infect 2020
The roles of rpsL, rrs, and gidB mutations in predicting streptomycin-resistant drugs used on clinical Mycobacterium tuberculosis isolates from Hebei Province, China. names it Int J Clin Exp Pathol 2019
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB. doi:10.1186/s40001-019-0397-2 Eur J Med Res 2019
Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan. doi:10.1038/s41598-019-51562-6 Sci Rep 2019
Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China. doi:10.2147/IDR.S209971 Infect Drug Resist 2019
Deciphering extracellular antibiotic resistance genes (eARGs) in activated sludge by metagenome. doi:10.1016/j.watres.2019.06.048 Water Res 2019
First genetic characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from Algeria. doi:10.1016/j.jgar.2019.05.010 J Glob Antimicrob Resist 2019
Rapid screening mutations of first-line-drug-resistant genes in Mycobacterium tuberculosis strains by allele-specific real-time quantitative PCR. doi:10.7717/peerj.6696 PeerJ 2019
A new oligonucleotide array for the detection of multidrug and extensively drug-resistance tuberculosis. doi:10.1038/s41598-019-39339-3 Sci Rep 2019
Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation. doi:10.1186/s12941-018-0300-y Ann Clin Microbiol Antimicrob 2019
The ribosomal maturation factor P from Mycobacterium smegmatis facilitates the ribosomal biogenesis by binding to the small ribosomal protein S12. doi:10.1074/jbc.RA118.002298 J Biol Chem 2019
New epidemic cluster of pre-extensively drug resistant isolates of Mycobacterium tuberculosis Ural family emerging in Eastern Europe. doi:10.1186/s12864-018-5162-3 BMC Genomics 2018
Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle. doi:10.1186/s12917-018-1623-9 BMC Vet Res 2018
Characterization of mutations conferring streptomycin resistance to multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar. doi:10.1016/j.tube.2018.05.003 Tuberculosis (Edinb) 2018
Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania. doi:10.1038/s41598-018-27962-5 Sci Rep 2018
Dissecting whole-genome sequencing-based online tools for predicting resistance in Mycobacterium tuberculosis: can we use them for clinical decision guidance? doi:10.1016/j.tube.2018.03.009 Tuberculosis (Edinb) 2018
Single-nucleotide polymorphisms related to fluoroquinolone and aminoglycoside resistance in Mycobacterium avium isolates. doi:10.2147/IDR.S160899 Infect Drug Resist 2018
Interaction between rpsL and gyrA mutations affects the fitness and dual resistance of Mycobacterium tuberculosis clinical isolates against streptomycin and fluoroquinolones. doi:10.2147/IDR.S152335 names it Infect Drug Resist 2018
Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates. doi:10.3343/alm.2018.38.4.316 Ann Lab Med 2018
Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania. doi:10.1016/j.tube.2018.02.004 Tuberculosis (Edinb) 2018
Multi- and Extensively Drug Resistant Mycobacterium tuberculosis in South Africa: a Molecular Analysis of Historical Isolates. doi:10.1128/JCM.01214-17 J Clin Microbiol 2018
Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii. doi:10.1128/AAC.01788-17 Antimicrob Agents Chemother 2018
Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol. doi:10.1089/mdr.2017.0294 Microb Drug Resist 2018
Molecular drug resistance profiles of Mycobacterium tuberculosis from sputum specimens using ion semiconductor sequencing. doi:10.1016/j.mimet.2017.12.003 J Microbiol Methods 2018
Molecular Mechanisms of Intrinsic Streptomycin Resistance in Mycobacterium abscessus. doi:10.1128/AAC.01427-17 Antimicrob Agents Chemother 2018
High Resolution Melting Curve Analysis for Rapid Detection of Streptomycin and Ethambutol Resistance in Mycobacterium tuberculosis. Maedica (Bucur) 2017
Mutation analysis for detection of drug resistance in mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa, Pakistan. J Pak Med Assoc 2017
Rapid Detection of Streptomycin-Resistant Mycobacterium tuberculosis by rpsL-Restriction Fragment Length Polymorphism. doi:10.4103/abr.abr_240_16 names it Adv Biomed Res 2017
In Silico Prediction of Antibiotic Resistance in Mycobacterium ulcerans Agy99 through Whole Genome Sequence Analysis. doi:10.4269/ajtmh.16-0478 Am J Trop Med Hyg 2017
Drug resistance and Mycobacterium tuberculosis strain diversity in TB/HIV co-infected patients in Ho Chi Minh city, Vietnam. doi:10.1016/j.jgar.2017.07.003 J Glob Antimicrob Resist 2017
A comparative study of phenotypic and genotypic first- and second-line drug resistance testing of Mycobacterium tuberculosis. doi:10.1016/j.biologicals.2017.07.003 Biologicals 2017
Screening mutations in drug-resistant Mycobacterium tuberculosis strains in Yunnan, China. doi:10.1016/j.jiph.2017.04.008 J Infect Public Health 2017
Mutations in Streptomycin Resistance Genes and Their Relationship to Streptomycin Resistance and Lineage of Mycobacterium tuberculosis Thai Isolates. doi:10.4046/trd.2017.80.2.159 Tuberc Respir Dis (Seoul) 2017
Frequency of rrs and rpsL mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from Iranian patients. doi:10.1016/j.jgar.2017.01.005 names it J Glob Antimicrob Resist 2017
Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China. doi:10.1371/journal.pone.0169413 PLoS One 2017
Screening for streptomycin resistance conferring mutations in Mycobacterium tuberculosis isolates from Iran. doi:10.1080/1120009X.2016.1169619 J Chemother 2017
Alternate efflux pump mechanism may contribute to drug resistance in extensively drug-resistant isolates of Mycobacterium tuberculosis. doi:10.1016/j.ijmyco.2016.09.064 Int J Mycobacteriol 2016
Mutations in rrs, rpsL and gidB in streptomycin-resistant Mycobacterium tuberculosis isolates from Thailand. doi:10.1016/j.jgar.2015.11.009 names it J Glob Antimicrob Resist 2016
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012. doi:10.1186/s12866-016-0699-2 BMC Microbiol 2016
Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance. doi:10.1186/s12916-016-0575-9 BMC Med 2016
Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda. doi:10.1016/j.meegid.2016.02.019 Infect Genet Evol 2016
Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis isolates in Sichuan, China and the association between Beijing-lineage and dual-mutation in gidB. doi:10.1016/j.tube.2015.09.004 Tuberculosis (Edinb) 2016
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement. doi:10.5588/ijtld.15.0221 Int J Tuberc Lung Dis 2016
Streptomycin affinity depends on 13 amino acids forming a loop in homology modelled ribosomal S12 protein (rpsL gene) of Lysinibacillus sphaericus DSLS5 associated with marine sponge (Tedania anhelans). doi:10.1080/07391102.2015.1073633 names it J Biomol Struct Dyn 2016
Fitness Costs of Drug Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis: A Household-Based Case-Control Study. doi:10.1093/infdis/jiv347 J Infect Dis 2016
Analysis of rpsL and rrs genes mutations related to streptomycin resistance in Mdr and Xdr clinical isolates of Mycobacterium tuberculosis. doi:10.5578/tt.6474 names it Tuberk Toraks 2015
Identification of mutations conferring streptomycin resistance in multidrug-resistant tuberculosis of China. doi:10.1016/j.diagmicrobio.2015.06.020 Diagn Microbiol Infect Dis 2015
Sequence Analysis of lip R: A Good Method for Molecular Epidemiology of Clinical Isolates of Mycobacterium tuberculosis. doi:10.1007/s00284-015-0856-0 Curr Microbiol 2015
Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan. doi:10.1371/journal.pone.0117771 PLoS One 2015
Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes. doi:10.1128/mBio.02273-14 mBio 2015
Molecular epidemiology of tuberculosis in Kaohsiung City located at southern Taiwan, 2000-2008. doi:10.1371/journal.pone.0117061 PLoS One 2015
Genotypic and phenotypic characteristics of aminoglycoside-resistant Mycobacterium tuberculosis isolates in Latvia. doi:10.1016/j.diagmicrobio.2014.12.004 Diagn Microbiol Infect Dis 2015
Evaluation of the MeltPro TB/STR assay for rapid detection of streptomycin resistance in Mycobacterium tuberculosis. doi:10.1016/j.tube.2014.12.004 Tuberculosis (Edinb) 2015
Evolution and transmission patterns of extensively drug-resistant tuberculosis in China. doi:10.1128/AAC.03504-14 Antimicrob Agents Chemother 2015
A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland. doi:10.1007/s10096-014-2202-z Eur J Clin Microbiol Infect Dis 2015
Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia. doi:10.1186/1471-2334-14-478 BMC Infect Dis 2014
Evaluation of gidB alterations responsible for streptomycin resistance in Mycobacterium tuberculosis. doi:10.1093/jac/dku273 J Antimicrob Chemother 2014
Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland. doi:10.1371/journal.pone.0100078 PLoS One 2014
Molecular analysis of the rpsL gene for rapid detection of streptomycin-resistant Mycobacterium tuberculosis: a meta-analysis. doi:10.3109/00365548.2014.918649 names it Scand J Infect Dis 2014
Sequence analysis for detection of drug resistance in Mycobacterium tuberculosis complex isolates from the Central Region of Cameroon. doi:10.1186/1471-2180-14-113 BMC Microbiol 2014
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China. doi:10.1128/AAC.02426-14 Antimicrob Agents Chemother 2014
Pyrosequencing for rapid detection of tuberculosis resistance in clinical isolates and sputum samples from re-treatment pulmonary tuberculosis patients. doi:10.1186/1471-2334-14-200 BMC Infect Dis 2014
Simplified microarray system for simultaneously detecting rifampin, isoniazid, ethambutol, and streptomycin resistance markers in Mycobacterium tuberculosis. doi:10.1128/JCM.00238-14 J Clin Microbiol 2014
A rapid fluorescence polarization-based method for genotypic detection of drug resistance in Mycobacterium tuberculosis. doi:10.1007/s00253-013-5356-1 Appl Microbiol Biotechnol 2014
GidB mutation as a phylogenetic marker for Q1 cluster Mycobacterium tuberculosis isolates and intermediate-level streptomycin resistance determinant in Lisbon, Portugal. doi:10.1111/1469-0691.12392 Clin Microbiol Infect 2014
Detection of streptomycin and quinolone resistance in Mycobacterium tuberculosis by a low-density DNA array. doi:10.1016/j.tube.2013.07.001 Tuberculosis (Edinb) 2013
High resolution melting curve assay for rapid detection of drug-resistant Mycobacterium tuberculosis. doi:10.1007/s10156-013-0636-3 J Infect Chemother 2013
Effect of ribosome-targeting antibiotics on streptomycin-resistant Mycobacterium mutants in the rpsL gene. doi:10.1016/j.ijantimicag.2013.04.001 names it Int J Antimicrob Agents 2013
Analysis of mutations in streptomycin-resistant strains reveals a simple and reliable genetic marker for identification of the Mycobacterium tuberculosis Beijing genotype. doi:10.1128/JCM.01944-12 J Clin Microbiol 2013
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea. doi:10.1016/j.diagmicrobio.2013.02.035 Diagn Microbiol Infect Dis 2013
Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea. doi:10.1007/s11274-013-1256-x World J Microbiol Biotechnol 2013
Molecular characterisation of drug resistance in Mycobacterium tuberculosis isolates from North India. doi:10.5588/ijtld.12.0319 Int J Tuberc Lung Dis 2013
Biological cost in Mycobacterium tuberculosis with mutations in the rpsL, rrs, rpoB, and katG genes. doi:10.1016/j.tube.2012.11.004 names it Tuberculosis (Edinb) 2013
rrs and rpsL mutations in streptomycin-resistant isolates of Mycobacterium tuberculosis from Mexico. doi:10.1016/j.jmii.2012.08.020 names it J Microbiol Immunol Infect 2013
A new multilocus sequence analysis scheme for Mycobacterium tuberculosis. doi:10.3967/0895-3988.2012.06.003 Biomed Environ Sci 2012
Phenotypic and genotypic characteristics of drug resistance in Mycobacterium tuberculosis isolates from pediatric population of Chennai, India. doi:10.4103/0255-0857.103761 Indian J Med Microbiol 2012
Drug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea. doi:10.1186/1471-2180-12-191 BMC Microbiol 2012
[A rapid screening program on the resistance to streptomycin and ethambutol in Mycobacterium tuberculosis isolates by PCR melting curve analysis]. Zhonghua Liu Xing Bing Xue Za Zhi 2012
Rapid detection of rifampicin, isoniazid and streptomycin resistance in Mycobacterium tuberculosis clinical isolates by high-resolution melting curve analysis. doi:10.1111/j.1365-2672.2012.05379.x J Appl Microbiol 2012
Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting. doi:10.1186/1471-2180-12-90 BMC Microbiol 2012
Association of streptomycin resistance mutations with level of drug resistance and Mycobacterium tuberculosis genotypes. doi:10.5588/ijtld.11.0202 Int J Tuberc Lung Dis 2012
Sequencing-based detection of drug-resistant Mycobacterium tuberculosis in patients with spinal tuberculosis. doi:10.1007/s00402-012-1506-7 Arch Orthop Trauma Surg 2012
High-resolution melting analysis for the rapid detection of fluoroquinolone and streptomycin resistance in Mycobacterium tuberculosis. doi:10.1371/journal.pone.0031934 PLoS One 2012
The TDR Tuberculosis Strain Bank: a resource for basic science, tool development and diagnostic services. doi:10.5588/ijtld.11.0223 Int J Tuberc Lung Dis 2012
Streptomycin resistance and lineage-specific polymorphisms in Mycobacterium tuberculosis gidB gene. doi:10.1128/JCM.00168-11 J Clin Microbiol 2011
High-resolution melting facilitates mutation screening of rpsL gene associated with streptomycin resistance in Mycobacterium tuberculosis. doi:10.1016/j.micres.2010.02.001 names it Microbiol Res 2011
A genotypic approach for detection, identification, and characterization of drug resistance in Mycobacterium ulcerans in clinical samples and isolates from Ghana. doi:10.4269/ajtmh.2010.10-0263 Am J Trop Med Hyg 2010
[The effects of gene mutation related to drug resistance and drug efflux pump in extensively drug-resistant tuberculosis clinical isolates]. Zhonghua Jie He He Hu Xi Za Zhi 2010
Streptomycin induced protein expression analysis in Mycobacterium tuberculosis by two-dimensional gel electrophoresis & mass spectrometry. Indian J Med Res 2010
Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of Barcelona. doi:10.1093/jac/dkq322 J Antimicrob Chemother 2010
Molecular characterization of drug-resistant Beijing family isolates of Mycobacterium tuberculosis from Tianjin, China. doi:10.1016/S0895-3988(10)60051-7 Biomed Environ Sci 2010
Mutation K42R in ribosomal protein S12 does not affect susceptibility of Mycobacterium smegmatis 16S rRNA A-site mutants to 2-deoxystreptamines. doi:10.1371/journal.pone.0011960 PLoS One 2010
One-tube loop-mediated isothermal amplification combined with restriction endonuclease digestion and ELISA for colorimetric detection of resistance to isoniazid, ethambutol and streptomycin in Mycobacterium tuberculosis isolates. doi:10.1016/j.mimet.2010.07.018 J Microbiol Methods 2010
[Molecular characterization of drug-resistant and extensive-drug resistant isolates of Mycobacterium tuberculosis in Shenzhen of China]. Zhonghua Jie He He Hu Xi Za Zhi 2010
Measurement of the rates of synthesis of three components of ribosomes of Mycobacterium fortuitum: a theoretical approach to qRT-PCR experimentation. doi:10.1371/journal.pone.0011575 PLoS One 2010
Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. doi:10.1128/JCM.01947-09 J Clin Microbiol 2010
Genetic characterisation of drug-resistant Mycobacterium tuberculosis in rural China: a population-based study. Int J Tuberc Lung Dis 2010
Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis. doi:10.1128/JCM.01476-09 J Clin Microbiol 2010
Analysis of rpsL and rrs mutations in Beijing and non-Beijing streptomycin-resistant Mycobacterium tuberculosis isolates from Singapore. doi:10.1111/j.1469-0691.2009.02800.x names it Clin Microbiol Infect 2010
Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco. doi:10.3855/jidc.125 J Infect Dev Ctries 2009
Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin. Indian J Exp Biol 2009
Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates in Guangdong, China. Jpn J Infect Dis 2009
Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression. doi:10.1371/journal.pone.0005923 PLoS One 2009
[Investigation of rpsL and rrs gene region mutations in streptomycin resistant Mycobacterium tuberculosis complex isolates]. names it Mikrobiyol Bul 2009
Association of mutations in rpsL gene with high degree of streptomycin resistance in clinical isolates of Mycobacterium tuberculosis in India. names it Indian J Med Res 2009
Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis. doi:10.1016/j.ijid.2008.10.006 Int J Infect Dis 2009
Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex. doi:10.1016/j.ijid.2008.03.025 Int J Infect Dis 2009
[Detection of streptomycin resistance in Mycobacterium tuberculosis clinical isolates by denaturing high-performance liquid chromatography and DNA sequencing]. Zhonghua Yi Xue Za Zhi 2008
Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective. doi:10.1089/mdr.2008.0798 Microb Drug Resist 2008
Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism. doi:10.1128/AAC.01570-07 Antimicrob Agents Chemother 2008
Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations. doi:10.1128/AAC.01124-07 Antimicrob Agents Chemother 2008
Detection of streptomycin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by denaturing HPLC analysis and DNA sequencing. doi:10.1016/j.micinf.2007.08.009 Microbes Infect 2007
Drug susceptibility of Spanish Mycobacterium tuberculosis complex isolates from animals. doi:10.1016/j.tube.2007.08.004 Tuberculosis (Edinb) 2007
Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. doi:10.1111/j.1469-0691.2007.01711.x names it Clin Microbiol Infect 2007
Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria. doi:10.1111/j.1365-2958.2006.05585.x Mol Microbiol 2007
Detection of multidrug resistance in Mycobacterium tuberculosis. doi:10.1128/JCM.00750-06 J Clin Microbiol 2007
Detection of streptomycin resistance in Mycobacterium tuberculosis clinical isolates using four molecular methods in China. doi:10.1016/S0379-4172(06)60096-6 Yi Chuan Xue Bao 2006
Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutations in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC, SURVEYOR nuclease. doi:10.1016/j.micinf.2005.06.008 Microbes Infect 2006
Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Düzce, Turkey. Jpn J Infect Dis 2005
Global analysis of proteins synthesized by Mycobacterium smegmatis provides direct evidence for physiological heterogeneity in stationary-phase cultures. doi:10.1128/JB.187.19.6691-6700.2005 J Bacteriol 2005
[Anti-drug pattern of drug-resistant Mycobacterium tuberculosis and analysis of mutation in drug-target genes]. doi:10.11150/kansenshogakuzasshi1970.79.388 Kansenshogaku Zasshi 2005
Microarray and allele specific PCR detection of point mutations in Mycobacterium tuberculosis genes associated with drug resistance. doi:10.1016/j.mimet.2005.04.026 J Microbiol Methods 2005
Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis. doi:10.1016/j.resmic.2004.06.007 names it Res Microbiol 2004
Molecular characterisation of streptomycin-resistant Mycobacterium tuberculosis strains isolated in Poland. Int J Tuberc Lung Dis 2004
Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis. doi:10.1086/421501 J Infect Dis 2004
Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates. doi:10.1016/j.mimet.2004.02.006 J Microbiol Methods 2004
Antimicrobial susceptibility determined by the E test, Löwenstein-Jensen proportion, and DNA sequencing methods among Mycobacterium tuberculosis isolates discrepancies, preliminary results. doi:10.1590/s0074-02762004000100019 Mem Inst Oswaldo Cruz 2004
Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. doi:10.1099/jmm.0.05343-0 J Med Microbiol 2004
[rpsL gene analysis associated with Streptomycin resistance in Mycobacterium tuberculosis]. names it Yi Chuan Xue Bao 2003
[Study on drug-resistance of Mycobacterium tuberculosis isolated from coal workers with silico-tuberculosis]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2002
[Clinical application and evaluation of the detection of five drugs resistance genes in Mycobacterium tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 2002
Temperature-mediated heteroduplex analysis performed by using denaturing high-performance liquid chromatography to identify sequence polymorphisms in Mycobacterium tuberculosis complex organisms. doi:10.1128/JCM.40.5.1610-1616.2002 J Clin Microbiol 2002
Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. doi:10.1128/AAC.46.2.443-450.2002 Antimicrob Agents Chemother 2002
Molecular identification of streptomycin monoresistant Mycobacterium tuberculosis related to multidrug-resistant W strain. doi:10.3201/eid0705.010512 Emerg Infect Dis 2001
Mechanisms of streptomycin resistance: selection of mutations in the 16S rRNA gene conferring resistance. doi:10.1128/AAC.45.10.2877-2884.2001 Antimicrob Agents Chemother 2001
Characterization of IS6110 restriction fragment length polymorphism patterns and mechanisms of antimicrobial resistance for multidrug-resistant isolates of Mycobacterium tuberculosis from a major reference hospital in Assiut, Egypt. doi:10.1128/JCM.39.6.2330-2334.2001 J Clin Microbiol 2001
Heteroresistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2001
Gene Replacement in Mycobacterium tuberculosis and Mycobacterium bovis BCG Using rpsL as a Dominant Negative Selectable Marker. doi:10.1385/1-59259-147-7:093 names it Methods Mol Med 2001
Rapid, simple, and culture-independent detection of rpsL codon 43 mutations that are highly predictive of streptomycin resistance in Mycobacterium tuberculosis. doi:10.4269/ajtmh.2000.63.56 names it Am J Trop Med Hyg 2000
[Molecular mechanisms of multidrug resistance in Mycobacterium tuberculosis]. doi:10.7888/juoeh.22.269 J UOEH 2000
Genetic antagonism and hypermutability in Mycobacterium smegmatis. doi:10.1128/JB.182.12.3331-3335.2000 J Bacteriol 2000
Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates. Chin Med J (Engl) 1999
Relationship between genetic alteration of the rpsL gene and streptomycin susceptibility of Mycobacterium tuberculosis in Japan. doi:10.1093/jac/43.2.281 names it J Antimicrob Chemother 1999
Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. doi:10.1054/tuld.1999.0222 Tuber Lung Dis 1999
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. doi:10.1054/tuld.1998.0002 Tuber Lung Dis 1998
[Mechanisms of drug-resistance in mycobacteria]. Nihon Rinsho 1998
[Multidrug-resistant tuberculosis. 2. Mechanisms of drug-resistance in Mycobacterium tuberculosis--genetic mechanisms of drug-resistance]. Kekkaku 1998
[Study on the molecular mechanism of multi-drug resistance in clinical isolates of Mycobacterium tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 1997
Molecular techniques in the diagnosis of drug-resistant tuberculosis. Ann Acad Med Singap 1997
[Rapid diagnosis of tuberculosis]. Kekkaku 1997
Characterization of the rpsL and rrs genes of streptomycin-resistant clinical isolates of Mycobacterium tuberculosis in Japan. doi:10.1046/j.1365-2672.1997.00279.x names it J Appl Microbiol 1997
[Relationship between streptomycin susceptibility and rpsL mutations of Mycobacterium tuberculosis strains]. names it Kekkaku 1997
Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. doi:10.1093/clinids/24.5.894 Clin Infect Dis 1997
Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance in Mycobacterium tuberculosis. doi:10.1006/mcpr.1996.0086 Mol Cell Probes 1997
Use of rpsL for dominance selection and gene replacement in Streptomyces roseosporus. doi:10.1128/jb.179.1.180-186.1997 names it J Bacteriol 1997
[Detection of M. tuberculosis streptomycin-resistant gene]. Zhonghua Jie He He Hu Xi Za Zhi 1996
Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis. doi:10.1128/AAC.40.11.2452 Antimicrob Agents Chemother 1996
Genetic analysis of the Mycobacterium smegmatis rpsL promoter. doi:10.1128/jb.178.12.3564-3571.1996 names it J Bacteriol 1996
Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City. doi:10.1128/AAC.40.5.1186 Antimicrob Agents Chemother 1996
Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. doi:10.1128/AAC.40.4.1024 names it Antimicrob Agents Chemother 1996
Antimicrobial agent resistance in mycobacteria: molecular genetic insights. doi:10.1128/CMR.8.4.496 Clin Microbiol Rev 1995
rpsL+: a dominant selectable marker for gene replacement in mycobacteria. doi:10.1111/j.1365-2958.1995.tb02324.x names it Mol Microbiol 1995
Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. doi:10.1093/infdis/171.4.954 J Infect Dis 1995
Cloning and sequence analysis of the rpsL and rpsG genes of Mycobacterium smegmatis and characterization of mutations causing resistance to streptomycin. doi:10.1128/jb.176.19.6153-6156.1994 names it J Bacteriol 1994
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. doi:10.1016/s0140-6736(94)91338-2 Lancet 1994
Streptomycin resistance in mycobacteria. doi:10.1128/AAC.38.2.238 Antimicrob Agents Chemother 1994
The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis. doi:10.1111/j.1365-2958.1993.tb00924.x names it Mol Microbiol 1993

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Genomic-neighbour overlap (structural caveat) co-directional · 0 % of gene

NeighbourrpsG (Rv0683, + strand)
Overlap1 bp, 0 % of this gene's length

co-directional overlap: ordinary (e.g. shared stop/start codons in an operon), not the Rv2438A-type artefact P20.1, derived from GFF3 gene coordinates, 2026-08-03.

Conditional expression context (iModulons)

Member of 1 independently-modulated gene set(s): Unc_4.

iModulon membership (independently-modulated gene sets from a 647-sample RNA-seq compendium): the conditional co-expression context. Co-expression is a regulatory context, NOT a molecular function. Source: iModulonDB / modulome_mtb (Yoo 2022).

CRISPRi vulnerability

Vulnerability index -15.36 (95% CI -16.87 to -13.84). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionProtein S12 is involved in the translation initiation step.

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb0701 · 100.0% identity
M. leprae ML1880c · 97.6% identity
M. marinum MMAR_1011 · 99.2% identity
M. smegmatis MSMEG_1398 · 99.2% identity
M. orygis RJtmp_000719 · 100.0% identity
M. abscessus MAB_3851c · 96.7% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WH63 SwissProt · reviewed · Evidence at protein level
UniProt nameSmall ribosomal subunit protein uS12
Curated functionWith S4 and S5 plays an important role in translational accuracy..; FUNCTION: Interacts with and stabilizes bases of the 16S rRNA that are involved in tRNA selection in the A site and with the mRNA backbone. Located at the interface of the 30S and 50S subunits, it traverses the body of the 30S subunit contacting proteins on the other side and probably holding the rRNA structure together. The combined cluster of proteins S8, S12 and S17 appears to hold together the shoulder and platform of the 30S subunit.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category J Translation, ribosomal structure and biogenesis
Preferred namerpsL
eggNOG descriptionInteracts with and stabilizes bases of the 16S rRNA that are involved in tRNA selection in the A site and with the mRNA backbone. Located at the interface of the 30S and 50S subunits, it traverses the body of the 30S subunit contacting proteins on the other side and probably holding the rRNA structure together. The combined cluster of proteins S8, S12 and S17 appears to hold together the shoulder and platform of the 30S subunit
Orthologous groupCOG0048
KEGG orthology K02950
KEGG pathways map03010
KEGG modules M00178, M00179
Gene Ontology (44) GO:0003674, GO:0003735, GO:0005198, GO:0005575, GO:0005622, GO:0005623, GO:0005737, GO:0005840, GO:0006412, GO:0006518, GO:0006807, GO:0008150 +32 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.335 · quasi-invariant (6 sites), pN/pS underpowered
Polymorphic sites (≥ 0.1% of strains) 3 synonymous, 3 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 98.8% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 13/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 87.8%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) essential

DeJesus 2017 callES · essential
What the call meansessential: insertions absent across the whole ORF
TA sites (Himar1) 8 in the ORF — 8 in the essential state, 0 growth-defect, 0 non-essential, 0 growth-advantage. Saturation 0.125, mean read count 1. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 8 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.
CaveatRead with some caution: only 8 TA (Himar1) sites in the whole ORF (atlas median 13). The DeJesus 2017 call rests on fewer independent observations than for a longer gene. If this gene overlaps a neighbour (see Genomic-neighbour overlap section below), some of these 8 sites may fall inside the neighbour's ORF rather than its own, leaving even fewer truly informative sites than the raw count suggests. (P20.3)

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Drug resistance (WHO catalogue) streptomycin

streptomycin8 catalogued resistance-associated variant(s)

This gene carries mutations classed Associated with resistance (WHO grade 1–2) in the consolidated catalogue (WHO 2nd ed. 2023 + tb-profiler). Only the R-associated tier is shown; "uncertain" and empirical-only signals are excluded. Test a specific strain or variant with the resistance tester. Research context, not a clinical diagnostic.

Proteomics (mass spectrometry) detected

MS detectiondetected in 11 of 16 independent MS datasets
Integrated abundance984.0 ppm · rank 234/3519 (93.4th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length124 aa
Molecular weight13.8 kDa
Theoretical pI11.37
GRAVY-0.814 (hydrophilic)
Aliphatic index76.9
Aromaticity0.032
Instability index31.9 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
Ribosom_S12_S23PF00164.32 3.9e-4118–123 Ribosomal protein S12/S23

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 7sfr (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 10 solved

PDBMethodResolutionCoverage
7sfr Electron Microscopy 2.6 Å 100%
7kgb Electron Microscopy 2.7 Å 100%
7mt7 Electron Microscopy 2.71 Å 100%
7mt2 Electron Microscopy 2.76 Å 100%
7msm Electron Microscopy 2.79 Å 100%
7mt3 Electron Microscopy 2.8 Å 100%
7msc Electron Microscopy 2.97 Å 100%
7msz Electron Microscopy 3.1 Å 100%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (10 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 95.5

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
8wib-assembly1_m 1.00 0.99 0.97 0.99 99% 98% / 100% 2.3e-21 sig 8wib-assembly1_m Cryo- EM structure of Mycobacterium smegmatis 70S ribosome, E- tRNA and RafH.
8cwo-assembly1_L 1.00 0.99 0.97 0.99 92% 98% / 100% 3.8e-21 sig 8cwo-assembly1_L Cutibacterium acnes 30S ribosomal subunit with Sarecycline bound, body domain only in the local refined map
7msz-assembly1_l 1.00 0.98 0.97 0.98 100% 98% / 100% 2.0e-19 sig 7msz-assembly1_l Mtb 70SIC in complex with MtbEttA at Trans_R1 state
8rdw-assembly1_L6 1.00 0.99 0.97 0.99 71% 98% / 100% 8.2e-19 sig 8rdw-assembly1_L6 Cryo-EM structure of P. urativorans 70S ribosome in complex with hibernation factor Balon and EF-Tu(GDP) (structure 3).
8ced-assembly1_L 1.00 0.98 0.98 0.89 65% 99% / 100% 2.3e-18 sig 8ced-assembly1_L Rnase R bound to a 30S degradation intermediate (State I - head-turning)

Foldseek search of the AlphaFold DB model (mean pLDDT 95.5, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 2

Upstream (5' on genome)Rv0681 (+ strand, 248 bp gap)
Downstream (3' on genome)rpsG (+ strand, -1 bp gap)
Predicted operon rpsL · rpsG

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 4: rpsL · rpsG · fusA1 · tuf — disagrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT0710) exponential phase: operon of 5, Rv0681 · Rv0682 · Rv0683 · Rv0684 · Rv0685 (coverage 330.8)
stationary phase: operon of 5, Rv0681 · Rv0682 · Rv0683 · Rv0684 · Rv0685 (coverage 86.73) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: rpsK (30S ribosomal protein S11), high confidence (score 1000, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair's experimental or database support is transferred from orthologous pairs in other proteomes only: nothing was measured in M. tuberculosis, so it is an association inferred by orthology rather than measured in this organism.

Showing the 15 strongest of this gene's 308 partners at medium confidence (168 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 308 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv0717 rpsN1 exp (transferred) curated 30S ribosomal protein S14 999 1000 coexpression:734 experimental:999 database:662
Rv1643 rplT exp (transferred) 50S ribosomal protein L20 999 1000 coexpression:861 experimental:999
Rv3442c rpsI exp (transferred) curated 30S ribosomal protein S9 999 1000 coexpression:861 experimental:999 database:844 textmining:516
Rv0700 rpsJ exp (transferred) curated 30S ribosomal protein S10 999 1000 coexpression:967 experimental:999 database:844 textmining:614
Rv0706 rplV exp (transferred) 50S ribosomal protein L22 999 1000 coexpression:888 experimental:999
Rv3459c rpsK exp (transferred) curated 30S ribosomal protein S11 999 1000 ctx cooccurence:512 coexpression:968 experimental:999 database:844
Rv0723 rplO exp (transferred) 50S ribosomal protein L15 999 1000 coexpression:865 experimental:999
Rv2442c rplU exp (transferred) 50S ribosomal protein L21 999 1000 coexpression:864 experimental:999
Rv0707 rpsC exp (transferred) curated 30S ribosomal protein S3 999 1000 ctx cooccurence:473 coexpression:864 experimental:999 database:844 textmining:512
Rv0722 rpmD exp (transferred) 50S ribosomal protein L30 999 1000 coexpression:863 experimental:999 textmining:451
Rv0056 rplI exp (transferred) 50S ribosomal protein L9 999 1000 coexpression:794 experimental:999
Rv0702 rplD exp (transferred) curated 50S ribosomal protein L4 999 1000 coexpression:958 experimental:999 database:844
Rv0719 rplF exp (transferred) 50S ribosomal protein L6 999 1000 ctx cooccurence:422 coexpression:905 experimental:999
Rv3443c rplM exp (transferred) 50S ribosomal protein L13 999 1000 coexpression:863 experimental:999 textmining:625
Rv3456c rplQ exp (transferred) 50S ribosomal protein L17 999 1000 coexpression:946 experimental:999

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: 30S ribosomal protein S12
  • MTBC0 PGAP product: 30S ribosomal protein S12
  • Pfam (hmmscan --cut_ga): Ribosom_S12_S23 PF00164.32 (E=4e-41)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_215196.1)
  • Domains: Pfam-A via hmmscan --cut_ga — Ribosom_S12_S23 (PF00164.32)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0048
  • Curated reference: UniProt P9WH63 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 95.5)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 308 functional partner(s); context anchor rpsK
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Drug resistance: consolidated catalogue, WHO 2nd ed. 2023 (9789240082410) + tb-profiler; only the resistance-associated tier (grade 1–2) is surfaced
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_000721|Rv0682|rpsL
MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG